SCHMITT DANIEL M
Transaction: 08/14/2026
SELL
Change
-272,056
Price
Not reported
Filing
08/14/2026
Type
SELL
Actuate Therapeutics Inc
ACTU • Biotechnology
$1.48
▲ +0.11 (+8.03%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$35.33M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 2.39Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:15 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.48
Change8.03%
Shares Out23.87M
Market Cap$35.33M
Enterprise Value$30.90M
52W Range0.90 - 9.22
Beta0.78
P/E-1.73
P/B35.72
P/FCF-1.78
EV/EBITDA-1.49
EV/FCF-1.56
Price$1.48
Change8.03%
Shares Out23.87M
Market Cap$35.33M
Enterprise Value$30.90M
52W Range0.90 - 9.22
Beta0.78
P/E-1.73
P/B35.72
P/FCF-1.78
EV/EBITDA-1.49
EV/FCF-1.56
Earnings Yield-57.89%
FCF Yield-56.14%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.05
Current Ratio2.39
Quick Ratio2.39
Target$21.00
Target Upside1318.92%
Target Median$21.00
Target Range21.00 - 21.00
Volume109.41K
Avg Volume242.79K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 2.39Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Price Target
2026-08-16
Low
$21.00
Mean
$21.00
Median
$21.00
High
$21.00
Insider Transactions
Recent executive and insider activity
⚠ 5 high-volume insider sells detected
SCHMITT DANIEL M
Transaction: 08/14/2026
SELL
Change
-120,521
Price
$1.01
Filing
08/14/2026
Type
SELL
Fletcher Aaron G.L.
Transaction: 05/21/2026
BUY
Change
+15,000
Price
$2.42
Filing
05/22/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| SCHMITT DANIEL M | SELL | -272,056 | Not reported | 08/14/2026 | 08/14/2026 |
| SCHMITT DANIEL M | SELL | -120,521 | $1.01 | 08/14/2026 | 08/14/2026 |
| Fletcher Aaron G.L. | BUY | +15,000 | $2.42 | 05/21/2026 | 05/22/2026 |
| Huber Martin H. Jr. | BUY | +15,000 | $2.42 | 05/21/2026 | 05/22/2026 |
| Keyes Jason A | BUY | +15,000 | $2.42 | 05/21/2026 | 05/22/2026 |
| RONNEBERG AMY L | BUY | +15,000 | $2.42 | 05/21/2026 | 05/22/2026 |
| Sawhney Roger | BUY | +15,000 | $2.42 | 05/21/2026 | 05/22/2026 |
| THOMSON TODD S | BUY | +15,000 | $2.42 | 05/21/2026 | 05/22/2026 |
| Zabrowski Dan | BUY | +15,000 | $2.42 | 05/21/2026 | 05/22/2026 |
| Huber Martin H. Jr. | OTHER | +30,000 | $3.00 | 05/01/2026 | 05/06/2026 |
| LYTLE PAUL J | BUY | +105,000 | $2.49 | 04/01/2026 | 04/01/2026 |
| Mazar Andrew Paul | BUY | +105,000 | $2.49 | 04/01/2026 | 04/01/2026 |
| SCHMITT DANIEL M | BUY | +237,000 | $2.49 | 04/01/2026 | 04/01/2026 |
| SCHMITT DANIEL M | SELL | -121,874 | $4.33 | 02/13/2026 | 02/13/2026 |
| SCHMITT DANIEL M | SELL | -272,055 | Not reported | 02/13/2026 | 02/13/2026 |
| THOMSON TODD S | SELL | -280,000 | $5.80 | 01/05/2026 | 01/07/2026 |
| Fletcher Aaron G.L. | BUY | +71,428 | $7.00 | 06/27/2025 | 06/30/2025 |
| Fletcher Aaron G.L. | BUY | +71,428 | $7.00 | 06/27/2025 | 06/30/2025 |
| Kreis Leslie W. | BUY | +71,428 | $7.00 | 06/27/2025 | 06/30/2025 |
| Kreis Leslie W. | BUY | +71,428 | $7.00 | 06/27/2025 | 06/30/2025 |